£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

US Cancer Diagnostics Lab Test Outlook 2023-2028 Study

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 19 days · 19 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 03 August 2026 07 August 2026 12 August 2026 16 August 2026 21 August 2026
View at Amazon ↗

Price data last checked 72 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 19 days • 1 price levels

Days at Price
19 days 0 5 10 14 19 £520 Days at Price

Price Analysis

Most common price: £520 (19 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 19 days

Description

This comprehensive study provides a detailed outlook for cancer diagnostics laboratory tests across the United States from 2023 to 2028. It focuses on latent demand, also known as potential industry earnings (P.I.E.), across approximately 12,600 cities. By providing estimates in millions of U.S. dollars, this report offers a statistical approach to understanding market opportunities. For each city included, the data reports the percent share relative to both the state and the entire nation. These comparative benchmarks help users quickly evaluate different locations against one another. This data is designed to support effective distribution and sales force strategies through economic analysis.

Key Features

Covers latent demand and potential industry earnings (P.I.E.) for cancer diagnostics laboratory tests across the United States.

Provides detailed estimates in millions of U.S. dollars for approximately 12,600 cities.

Includes comparative benchmarks showing the percent share of each city relative to its state and the U.S. as a whole.

Supports distribution and sales force strategies through detailed statistical and economic data.

Offers a specific market outlook for the period spanning 2023 through 2028.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in India
99% match

The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in India

£515.00 15 Aug 2026
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
99% match

The 2023-2028 Outlook for Cancer Testing-Screening in the United States

£520.00 30 Sep 2026
The 2023-2028 Outlook for Cancer Testing-Screening in India
99% match

The 2023-2028 Outlook for Cancer Testing-Screening in India

£515.00 01 Oct 2026
The 2023-2028 World Outlook for Cancer Diagnostics Laboratory Tests
99% match

The 2023-2028 World Outlook for Cancer Diagnostics Laboratory Tests

Price unavailable
The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in China
99% match

The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in China

£495.00 15 Aug 2026
The 2025-2030 World Outlook for Cancer Diagnostics Laboratory Tests
99% match

The 2025-2030 World Outlook for Cancer Diagnostics Laboratory Tests

Price unavailable
The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in Japan
99% match

The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in Japan

£495.00 22 Aug 2026
The 2023-2028 Outlook for Cancer Screenings in the United States
98% match

The 2023-2028 Outlook for Cancer Screenings in the United States

£520.00 20 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care in the United States
98% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 22 Aug 2026
The 2025-2030 World Outlook for Next Generation Cancer Diagnostics
98% match

The 2025-2030 World Outlook for Next Generation Cancer Diagnostics

Price unavailable
The 2023-2028 Outlook for Cancer Testing-Screening in China
98% match

The 2023-2028 Outlook for Cancer Testing-Screening in China

£495.00 02 Oct 2026
The 2021-2026 World Outlook for Cancer Biomarkers
98% match

The 2021-2026 World Outlook for Cancer Biomarkers

£795.00 21 Aug 2026
The 2023-2028 Outlook for Cancer Testing-Screening in Japan
98% match

The 2023-2028 Outlook for Cancer Testing-Screening in Japan

£495.00 02 Oct 2026
India Cancer Supportive Care Drugs Outlook 2023-2028
98% match

India Cancer Supportive Care Drugs Outlook 2023-2028

£515.00 21 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
98% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 21 Aug 2026
Clinical Chemistry Analyzers Outlook 2023-2028 - US Study
98% match

Clinical Chemistry Analyzers Outlook 2023-2028 - US Study

£520.00 18 Aug 2026
The 2023-2028 Outlook for Lung Cancer Screening Software in the United States
98% match

The 2023-2028 Outlook for Lung Cancer Screening Software in the United States

£520.00 19 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
US Cancer Diagnostics Lab Test Outlook 2023-2028 Study
98% match

US Cancer Diagnostics Lab Test Outlook 2023-2028 Study

£490.00 24 Aug 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States

£520.00 01 Oct 2026
The 2023-2028 Outlook for Lung Cancer Screening Software in India
98% match

The 2023-2028 Outlook for Lung Cancer Screening Software in India

£515.00 21 Aug 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India
97% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India

£515.00 02 Oct 2026
The 2023 Report on Head and Neck Cancer Diagnostics: World Market Segmentation by City
97% match

The 2023 Report on Head and Neck Cancer Diagnostics: World Market Segmentation by City

£795.00 19 Aug 2026